**Core Concept**
Varicella vaccine is a live attenuated vaccine designed to protect against chickenpox, a highly contagious illness caused by the varicella-zoster virus (VZV). The vaccine stimulates the body to produce immunity against VZV without causing the full-blown disease.

**Why the Correct Answer is Right**
The varicella vaccine contains a weakened form of the VZV virus, which triggers a mild immune response in the body. This response primes the immune system to recognize and fight the virus if exposed to it in the future. The vaccine is typically administered to children in two doses, with the first dose given at 12-15 months and the second dose at 4-6 years. The vaccine has been shown to be highly effective in preventing severe cases of chickenpox, particularly in children who are immunocompromised.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the varicella vaccine is a live attenuated vaccine, which is different from an inactivated vaccine. Inactivated vaccines contain a killed virus or bacteria, whereas live attenuated vaccines contain a weakened form of the virus or bacteria.
**Option B:** This option is incorrect because the varicella vaccine is not a combination vaccine, which typically contains multiple antigens (e.g., MMR vaccine contains measles, mumps, and rubella antigens). The varicella vaccine is a single-antigen vaccine.

**Clinical Pearl / High-Yield Fact**
The varicella vaccine is not recommended for individuals with a history of severe allergic reactions to previous doses of the vaccine or its components. Additionally, the vaccine is not recommended for individuals with weakened immune systems, such as those with HIV/AIDS or undergoing chemotherapy.

**Correct Answer:** C.